₹0.03
(Market cap
₹7 Cr
Revenue (TTM)
₹12 Cr
P/E Ratio
--
P/B Ratio
0.2
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹0 Cr
-
ROE
0.3 %
-
ROCE
0.3 %
-
Industry P/E
26.81
-
EV/EBITDA
-33.3
-
Debt to Equity
0
-
Book Value
₹17.9
-
EPS
₹0
-
Face value
10
-
Shares outstanding
24,900,000
7 Years Aggregate
CFO
₹-40.06 Cr
EBITDA
₹-5.17 Cr
Net Profit
₹3.98 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
EVOQ Remedies
| -13.5 | -20.5 | -6.4 | -38.8 | -40.7 | -- | -- |
|
BSE Healthcare
| 9.1 | 1.2 | 7.9 | 7.7 | 25.1 | 13.2 | 12.3 |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
EVOQ Remedies
| -61.0 | -46.8 | 3.9 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
EVOQ Remedies
|
2.8 | 6.9 | 11.8 | 0.1 | -- | 0.3 | -- | 0.2 |
| 3,131.0 | 39,096.7 | 5,452.9 | 1,056.0 | 22.4 | 23.9 | 37 | 8.6 | |
| 8,249.5 | 20,609.8 | 2,275.6 | 187.5 | 10.3 | 22.9 | 109.9 | 23.6 | |
| 2,407.8 | 18,328.7 | 2,187.2 | 649.7 | 31.5 | 19 | 28.6 | 5.1 | |
| 1,728.3 | 10,570.9 | 1,196.4 | 149.4 | -- | 27.5 | 57.1 | 14.2 | |
| 1,404.6 | 19,439.6 | 3,129.4 | 647.4 | 26.9 | 18.1 | 31.4 | 5.0 | |
| 2,257.7 | 36,308.8 | 4,147.8 | 709.5 | 22.3 | 19.1 | 51.2 | 8.7 | |
| 4,509.2 | 20,631.8 | 2,519.7 | 722.4 | 33.6 | 18.8 | 28.6 | 4.9 | |
| 6,287.0 | 10,413.7 | 1,408.0 | 326.9 | 30.8 | 57.1 | 31.9 | 19.9 | |
| 546.8 | 10,682.7 | 1,538.1 | 226.2 | 20.4 | 9 | 43.9 | 4.1 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About EVOQ Remedies
Wholesale of pharmaceutical and medical goods
-
Incorporated
2010
-
Chairman
--
-
Managing Director
Bhumishth Patel
-
Headquarters
Ahmedabad, Gujarat
-
Website
Looking for more details about EVOQ Remedies Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
FAQs for EVOQ Remedies
What is the current share price of EVOQ Remedies Ltd Today?
The share price of EVOQ Remedies Ltd is ₹2.76 (BSE) as of 12-Jun-2026 IST. EVOQ Remedies Ltd has given a return of -40.72% in the last 3 years.
What is the current PB & PE ratio of EVOQ Remedies Ltd?
Since, TTM earnings of EVOQ Remedies Ltd is negative, P/E ratio is not available.
The P/B ratio of EVOQ Remedies Ltd is 0.15 times as on 12-Jun-2026, a 97 discount to its peers’ median range of 4.65 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
72.32
|
0.14
|
|
2024
|
26.07
|
0.47
|
|
2023
|
10.91
|
0.71
|
|
2022
|
28.17
|
1.33
|
|
2021
|
0.00
|
0.00
|
What is the 52 Week High and Low of EVOQ Remedies Ltd?
The 52-week high and low of EVOQ Remedies Ltd are Rs 6.11 and Rs 2.27 as of 13-Jun-2026.
What is the market cap of EVOQ Remedies Ltd?
EVOQ Remedies Ltd has a market capitalisation of ₹ 7 Cr as on 12-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in EVOQ Remedies Ltd?
Before investing in EVOQ Remedies Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.